论文信息 - Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWTand ERaMUTbreast cancer - 字舞流文

Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWTand ERaMUTbreast cancer

M. Hao | M. Warmuth | M. Korpal | D. Juric | S. Johnston | T. Pluard | A. Gualberto | B. Destenaves | Lihua Yu | Zhaojie Zhang | N. Larsen | X. Puyang | John Y. Wang | Lei Gao | V. Rimkunas | D. Bolduc | E. Hamilton | T. Sahmoud | Judy S. Wang | Tuong-Vi Nguyen | F. Vaillancourt | J. Schindler | N. Rioux | A. Kim | Peter C. Smith | Guo-Zhu Zheng | S. Yao | Craig Furman | Subhasree Das | S. Irwin | D. Banka | M. Pipas | Prajapati Sudeep | P. Zhu | Michael Thomas | J. J. Joshi | Wu Zhenhua | Huilan Yao